SHA:600196 Revenue

Shanghai Fosun Pharmaceutical (Group) had revenue of 10.07B CNY in the quarter ending March 31, 2026, with 6.93% growth. This brings the company's revenue in the last twelve months to 42.31B, up 4.92% year-over-year. In the year 2025, Shanghai Fosun Pharmaceutical (Group) had annual revenue of 41.66B with 1.45% growth.

Revenue (ttm)

42.31B

Revenue Growth

+4.92%

P/S Ratio

1.48

Revenue / Employee

1.04M

Employees

40,603

Market Cap

62.52B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	41.66B	594.42M	1.45%
Dec 31, 2024	41.07B	-332.34M	-0.80%
Dec 31, 2023	41.40B	-2.55B	-5.81%
Dec 31, 2022	43.95B	4.94B	12.66%
Dec 31, 2021	39.01B	8.70B	28.72%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Shenzhen Salubris Pharmaceuticals	4.52B
Huadong Medicine	44.06B
China Resources Sanjiu Medical & Pharmaceutical	32.88B
Yunnan Baiyao Group Co.,Ltd	41.19B
Beijing Tongrentang	17.26B
Zhejiang NHU Company	22.25B
Dong-E-E-Jiao	6.80B
Changchun High-Tech Industry (Group)	11.67B

Revenue Rankings

Shanghai Fosun Pharmaceutical (Group) News

2 years ago - Generic drugmakers start shipping copies of Takeda's ADHD drug Vyvanse - Reuters
4 years ago - Fosun Pharma Shares Gain After Tie-Up With New Covid Drug Supplier Genuine Biotech - Forbes
5 years ago - Fosun Pharma shares tumble more than 5% as Hong Kong suspends BioNTech Covid vaccinations - CNBC

More News